Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 203228
Gene Symbol: C9orf72
C9orf72
0.010 Biomarker phenotype BEFREE C9orf72-associated parkinsonism predominantly consisted in a hypokinetic-rigid syndrome without resting tremor (61%), with both asymmetric (59%) and symmetric (41%) distributions. 26810719 2016
Entrez Id: 8575
Gene Symbol: PRKRA
PRKRA
0.010 Biomarker phenotype BEFREE Molecular screening for DYT1, DYT5, DYT6, DYT11, and DYT16 dystonia genes was performed in all cases who met the following criteria at the time of SPECT scan: (1) clinical diagnosis of PD; (2) normal dopamine transporter SPECT; (3) asymmetric rest tremor, with or without postural/kinetic component; (4) ≥ 12-month follow-up; and (5) normal brain MRI. 25150291 2014
Entrez Id: 80208
Gene Symbol: SPG11
SPG11
0.010 Biomarker phenotype BEFREE Parkinsonism occurred during the very early stages of SPG11 in both patients, being in one the inaugural symptom of the disease presented as a resting tremor with akinesia, rigidity and expressing an initial moderate levodopa-response that progressively weakened. 19224311 2009
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.010 GeneticVariation phenotype BEFREE We studied the association between polymorphisms of genes coding for dopamine D(2) (DRD2), dopamine D(3) (DRD3), serotonin 2(a) (HTR2A), and serotonin 2(c) (HTR2C) receptors and Antipsychotic-Induced Parkinsonism (AIP), rigidity, bradykinesia, and rest-tremor in African-Caribbeans treated with antipsychotics. 18389501 2008
Entrez Id: 3356
Gene Symbol: HTR2A
HTR2A
0.010 Biomarker phenotype BEFREE We studied the association between polymorphisms of genes coding for dopamine D(2) (DRD2), dopamine D(3) (DRD3), serotonin 2(a) (HTR2A), and serotonin 2(c) (HTR2C) receptors and Antipsychotic-Induced Parkinsonism (AIP), rigidity, bradykinesia, and rest-tremor in African-Caribbeans treated with antipsychotics. 18389501 2008
Entrez Id: 3358
Gene Symbol: HTR2C
HTR2C
0.010 GeneticVariation phenotype BEFREE We studied the association between polymorphisms of genes coding for dopamine D(2) (DRD2), dopamine D(3) (DRD3), serotonin 2(a) (HTR2A), and serotonin 2(c) (HTR2C) receptors and Antipsychotic-Induced Parkinsonism (AIP), rigidity, bradykinesia, and rest-tremor in African-Caribbeans treated with antipsychotics. 18389501 2008
Entrez Id: 1814
Gene Symbol: DRD3
DRD3
0.010 Biomarker phenotype BEFREE We studied the association between polymorphisms of genes coding for dopamine D(2) (DRD2), dopamine D(3) (DRD3), serotonin 2(a) (HTR2A), and serotonin 2(c) (HTR2C) receptors and Antipsychotic-Induced Parkinsonism (AIP), rigidity, bradykinesia, and rest-tremor in African-Caribbeans treated with antipsychotics. 18389501 2008
Entrez Id: 5071
Gene Symbol: PRKN
PRKN
0.010 GeneticVariation phenotype BEFREE In this report, we use RT-PCR to detect compound heterozygous deletions of the parkin gene in fibroblasts from two cases of middle age-onset familial parkinsonism with lower extremities-dominant resting tremor and mild cogwheel rigidity. 16517073 2006
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.030 Biomarker phenotype BEFREE There was no significant relationship between rest tremor severity and pallidal DAT either in the tremor-dominant subgroup or in the total PD population. 29503156 2018
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.030 Biomarker phenotype BEFREE Fifty-six patients (52.8%) were diagnosed as having concomitant parkinsonism with rigidity and resting tremor and dopamine transporter reduction in the basal ganglia. 30222946 2018
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.030 GeneticVariation phenotype BEFREE Molecular screening for DYT1, DYT5, DYT6, DYT11, and DYT16 dystonia genes was performed in all cases who met the following criteria at the time of SPECT scan: (1) clinical diagnosis of PD; (2) normal dopamine transporter SPECT; (3) asymmetric rest tremor, with or without postural/kinetic component; (4) ≥ 12-month follow-up; and (5) normal brain MRI. 25150291 2014
Entrez Id: 6311
Gene Symbol: ATXN2
ATXN2
0.100 Biomarker phenotype HPO
Entrez Id: 27235
Gene Symbol: COQ2
COQ2
0.100 Biomarker phenotype HPO
Entrez Id: 291
Gene Symbol: SLC25A4
SLC25A4
0.100 Biomarker phenotype HPO
Entrez Id: 10159
Gene Symbol: ATP6AP2
ATP6AP2
0.100 Biomarker phenotype HPO
Entrez Id: 126
Gene Symbol: ADH1C
ADH1C
0.100 Biomarker phenotype HPO
Entrez Id: 11253
Gene Symbol: MAN1B1
MAN1B1
0.100 Biomarker phenotype HPO
Entrez Id: 6315
Gene Symbol: ATXN8OS
ATXN8OS
0.100 Biomarker phenotype HPO
Entrez Id: 11232
Gene Symbol: POLG2
POLG2
0.100 Biomarker phenotype HPO
Entrez Id: 8913
Gene Symbol: CACNA1G
CACNA1G
0.100 Biomarker phenotype HPO
Entrez Id: 8867
Gene Symbol: SYNJ1
SYNJ1
0.100 Biomarker phenotype HPO
Entrez Id: 26058
Gene Symbol: GIGYF2
GIGYF2
0.100 Biomarker phenotype HPO
Entrez Id: 4929
Gene Symbol: NR4A2
NR4A2
0.100 Biomarker phenotype HPO
Entrez Id: 9829
Gene Symbol: DNAJC6
DNAJC6
0.100 Biomarker phenotype HPO
Entrez Id: 9627
Gene Symbol: SNCAIP
SNCAIP
0.100 Biomarker phenotype HPO